These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 1393633)

  • 1. [Bacterial resistance to aminoglycoside antibiotics].
    Kettner M; Macicková T
    Bratisl Lek Listy; 1992 Apr; 93(4):175-8. PubMed ID: 1393633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
    Kettner M; Krćméry V
    Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria.
    Kettner M; Navarová J; Lebek G; Krcméry V
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):372-82. PubMed ID: 6091367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside resistance patterns in Turkey.
    Akalin HE; Torun M; Alacam R
    Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia].
    Kettner M; Miller GH; Inouye S
    Bratisl Lek Listy; 1992 Mar; 93(3):131-5. PubMed ID: 1525686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
    J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferable amikacin resistance in gram-negative bacterial isolates.
    Kallová J; Macicková T; Majtánová A; Aghová A; Adam D; Kettner M
    Chemotherapy; 1995; 41(3):187-92. PubMed ID: 7656664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
    Miller GH; Sabatelli FJ; Naples L; Hare RS; Shaw KJ
    J Chemother; 1995 Jun; 7 Suppl 2():31-44. PubMed ID: 8622109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres.
    Lovering AM; Bywater MJ; Holt HA; Champion HM; Reeves DS
    J Antimicrob Chemother; 1988 Dec; 22(6):823-39. PubMed ID: 3243733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used.
    Busch-Sørensen C; Sönmezoglu M; Frimodt-Møller N; Højbjerg T; Miller GH; Espersen F
    APMIS; 1996 Oct; 104(10):763-8. PubMed ID: 8980628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical and genetic mechanisms for bacteria to acquire aminoglycoside antibiotic resistance].
    Hotta K
    Nihon Rinsho; 1997 May; 55(5):1231-7. PubMed ID: 9155180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of dactimicin to aminoglycoside-modifying enzymes.
    Gomez-Lus R; Marco MA; Gomez-Lus ML
    Drugs Exp Clin Res; 1987; 13(12):731-5. PubMed ID: 3447876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside resistance. Enzymatic mechanisms in clinical bacterial strains in Slovakia during the last decade.
    Kallová J; Kettner M; Macicková T; Milosovic P; Langsádl L
    FEMS Immunol Med Microbiol; 1997 Sep; 19(1):89-94. PubMed ID: 9322073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey.
    Over U; Gür D; Unal S; Miller GH;
    Clin Microbiol Infect; 2001 Sep; 7(9):470-8. PubMed ID: 11678929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.